Improved survival with ipilimumab in patients with metastatic melanoma.

Hodi FS, O'Day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, Gonzalez R, Robert C, Schadendorf D, Hassel JC, Akerley W, van den Eertwegh AJ, Lutzky J, Lorigan P, Vaubel JM, Linette GP, Hogg D, Ottensmeier CH, Lebbé C, Peschel C, Quirt I, Clark JI, Wolchok JD, Weber JS, Tian J, Yellin MJ, Nichol GM, Hoos A, Urba WJ
N Engl J Med. 2010 363 (8): 711-23

PMID: 20525992 · PMCID: PMC3549297 · DOI:10.1056/NEJMoa1003466

MeSH Terms (15)

Antibodies, Monoclonal Antigens, CD Cancer Vaccines Combined Modality Therapy CTLA-4 Antigen Double-Blind Method Female Humans Ipilimumab Kaplan-Meier Estimate Male Melanoma Middle Aged Skin Neoplasms Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities:

Links